Home › NDC Lookup › Ingredients › Ruxolitinib
📦 NDC / package directory — not a drug information page

Ruxolitinib NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Ruxolitinib products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Looking for uses, warnings & side effects? Read our Ruxolitinib drug information page →

Key stats

26
Package NDCs
33
Products
33
Active listings
0
Discontinued
4
Labelers
12
Strengths
4
Dosage forms
1
With NADAC pricing

By strength, form & labeler

NDC products by strength
RUXOLITINIB 15 mg/1 4
RUXOLITINIB 5 mg/1 4
RUXOLITINIB 10 mg/1 4
RUXOLITINIB 20 mg/1 4
RUXOLITINIB 25 mg/1 4
RUXOLITINIB 11 mg/1 2
RUXOLITINIB 55 mg/1 2
RUXOLITINIB PHOSPHATE 15 mg/g 2
RUXOLITINIB 22 mg/1 2
RUXOLITINIB 44 mg/1 2
By dosage form
TABLET 20
TABLET, EXTENDED RELEASE 10
CREAM 2
POWDER 1
Top labelers
Incyte Corporation 22
Catalent Pharma Solutions, LLC 5
Patheon Manufacturing Services LLC 5
STERLING SPA 1

Browse records — 33 products

Drug / product Billing NDC NADAC / unit Status
JAKAFI ruxolitinib 10 mg/1 TABLET Incyte · NDC 50881-0010-01 · 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01) 50881-0010-01 — On market View →
JAKAFI ruxolitinib 25 mg/1 TABLET Incyte · NDC 50881-0025-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-025-60) 50881-0025-60 — On market View →
JAKAFI ruxolitinib 15 mg/1 TABLET Incyte · NDC 50881-0015-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-015-60) 50881-0015-60 — On market View →
JAKAFI ruxolitinib 20 mg/1 TABLET Incyte · NDC 50881-0020-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-020-60) 50881-0020-60 — On market View →
JAKAFI ruxolitinib 5 mg/1 TABLET Incyte · NDC 50881-0005-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-005-60) 50881-0005-60 — On market View →
JAKAFI ruxolitinib 5 mg/1 TABLET Incyte · NDC 50881-0005-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-005-60) 50881-0005-60 — On market View →
JAKAFI ruxolitinib 25 mg/1 TABLET Incyte · NDC 50881-0025-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-025-60) 50881-0025-60 — On market View →
JAKAFI ruxolitinib 15 mg/1 TABLET Incyte · NDC 50881-0015-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-015-60) 50881-0015-60 — On market View →
JAKAFI ruxolitinib 10 mg/1 TABLET Incyte · NDC 50881-0010-01 · 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01) 50881-0010-01 — On market View →
JAKAFI ruxolitinib 20 mg/1 TABLET Incyte · NDC 50881-0020-60 · 60 TABLET in 1 BOTTLE, PLASTIC (50881-020-60) 50881-0020-60 — On market View →
JAKAFI XR ruxolitinib 11 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0011-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-011-08) 50881-0011-08 — On market View →
JAKAFI XR ruxolitinib 55 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0055-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-055-08) 50881-0055-08 — On market View →
JAKAFI XR ruxolitinib 44 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0044-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08) 50881-0044-08 — On market View →
JAKAFI XR ruxolitinib 33 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0033-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08) 50881-0033-08 — On market View →
JAKAFI XR ruxolitinib 22 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0022-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08) 50881-0022-08 — On market View →
JAKAFI XR ruxolitinib 11 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0011-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-011-08) 50881-0011-08 — On market View →
JAKAFI XR ruxolitinib 22 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0022-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08) 50881-0022-08 — On market View →
JAKAFI XR ruxolitinib 55 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0055-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-055-08) 50881-0055-08 — On market View →
JAKAFI XR ruxolitinib 33 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0033-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08) 50881-0033-08 — On market View →
JAKAFI XR ruxolitinib 44 mg/1 TABLET, EXTENDED RELEASE Incyte · NDC 50881-0044-08 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08) 50881-0044-08 — On market View →
OPZELURA ruxolitinib 15 mg/g CREAM Incyte · NDC 50881-0007-04 · 1 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE 50881-0007-04 — On market View →
OPZELURA ruxolitinib 15 mg/g CREAM Incyte · NDC 50881-0007-04 · 1 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE 50881-0007-04 — On market View →
RUXOLITINIB 15 mg/1 TABLET Patheon · NDC 63552-0051-00 · 20000 TABLET in 1 DRUM (63552-051-00) 63552-0051-00 — On market View →
ruxolitinib 5 mg/1 TABLET Catalent · NDC 11014-0449-02 · 1 BAG in 1 DRUM (11014-0449-2) / 75000 TABLET in 1 BAG 11014-0449-02 — On market View →
RUXOLITINIB 20 mg/1 TABLET Patheon · NDC 63552-0052-00 · 20000 TABLET in 1 DRUM (63552-052-00) 63552-0052-00 — On market View →
RUXOLITINIB 1 kg/kg POWDER STERLING · NDC 64918-1902-01 · 20 kg in 1 DRUM (64918-1902-1) 64918-1902-01 — On market View →
ruxolitinib 25 mg/1 TABLET Catalent · NDC 11014-0453-02 · 1 BAG in 1 DRUM (11014-0453-2) / 12000 TABLET in 1 BAG 11014-0453-02 — On market View →
ruxolitinib 10 mg/1 TABLET Catalent · NDC 11014-0450-02 · 1 BAG in 1 DRUM (11014-0450-2) / 40000 TABLET in 1 BAG 11014-0450-02 — On market View →
ruxolitinib 15 mg/1 TABLET Catalent · NDC 11014-0451-02 · 1 BAG in 1 DRUM (11014-0451-2) / 19997 TABLET in 1 BAG 11014-0451-02 — On market View →
RUXOLITINIB 5 mg/1 TABLET Patheon · NDC 63552-0049-00 · 75000 TABLET in 1 DRUM (63552-049-00) 63552-0049-00 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.